MedTrace Logo

Genetic Autopsy and Sudden Death

NCT02920203 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-11-06

No results posted yet for this study

Summary

The purpose of the study is to better identify hereditary cardiac causes of sudden unexpected death in young subjects through Next-Generation Sequencing of autopsy tissue

Conditions

  • Sudden Death

Interventions

GENETIC

Heart and spleen tissue

genetic sequencing

Sponsors & Collaborators

  • Pathology department and forensic Institute, Raymond Poincaré hospital, Garches

    collaborator UNKNOWN

  • Referal Center for Inherited cardiac diseases, Pitié Salpêtrière Hospital, Paris

    collaborator UNKNOWN

  • Pitié-Salpêtrière Hospital

    collaborator OTHER

  • Clinical research Unit, Ambroise Paré Hospital, Boulogne Billancourt

    collaborator UNKNOWN

  • Cardiogenetic and molecular and cellular myogenetic functionnal unit Pitié Salpêtrière hospital, Paris

    collaborator UNKNOWN

  • Molecular and medical Virology Laboratory, Medical School, Reims

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Geoffroy Lorin de la Grandmaison, Pr · Assistance Publique Hoptiaux de Paris

  • Philippe Charron, MD, PhD · +33 (0)1 42 16 13 47

Eligibility

Min Age
2 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-11
Primary Completion
2020-09-30
Completion
2020-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920203 on ClinicalTrials.gov